down arrow

Elevance Health, Inc.

  • Market Cap: Large Cap
  • Industry: Healthcare Services
  • ISIN: US0367521038
USD
333.49
2.74 (0.83%)

Dec 04

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

328.32336.43

52 Week

273.71458.75
Valuation
Technical
Day's Volume

CASH

373.62 k

Shareholding (Mar 2025)

FII

22.43%

Held by 567 FIIs

DII

40.53%

Held by 61 DIIs

Promoter

0.22%

How big is Elevance Health, Inc.?

22-Jun-2025

As of Jun 18, Elevance Health, Inc. has a market capitalization of $84.77 billion, with net sales of $0 million and a net profit of $5.91 billion over the latest four quarters. The company reported shareholder's funds of $41.32 billion and total assets of $116.89 billion as of Dec 24.

Market Cap: As of Jun 18, Elevance Health, Inc. has a market capitalization of 84,768.40 million, categorizing it as a Large Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Elevance Health, Inc. reported net sales of 0.00 million and a net profit of 5,906.00 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 41,315.00 million and total assets of 116,889.00 million.

Read More

What does Elevance Health, Inc. do?

22-Jun-2025

Elevance Health, Inc. is a health benefits company with a market cap of approximately $84.77 billion, reporting a net profit of $2.18 billion in Q1 2025. Key metrics include a P/E ratio of 15.00 and a dividend yield of 141.81%.

Overview:<BR>Elevance Health, Inc. is a health benefits company operating in the Healthcare Services industry with a large market capitalization.<BR><BR>Financial Snapshot:<BR>Most recent Net Profit: 2,184 Million (Quarterly Results - Mar 2025)<BR>Market cap: USD 84,768.40 Million (Large Cap)<BR><BR>Key Metrics:<BR>P/E: 15.00<BR>Dividend Yield: 141.81%<BR>Debt Equity: -0.09<BR>Return on Equity: 13.90%<BR>Price to Book: 1.99<BR><BR>Contact Details:<BR>Address: 220 Virginia Avenue, INDIANAPOLIS IN: 46204<BR>Tel: 1 317 4886000<BR>Website: https://www.antheminc.com/

Read More

Who are in the management team of Elevance Health, Inc.?

22-Jun-2025

As of March 2022, the management team of Elevance Health, Inc. includes Independent Chairman Ms. Elizabeth Tallett, CEO Ms. Gail Boudreaux, and several Independent Directors: Mr. R. Kerry Clark, Mr. Robert Dixon, Mr. Lewis Hay, Ms. Julie Hill, and Dr. Bahija Jallal. They are responsible for the company's strategic direction and governance.

As of March 2022, the management team of Elevance Health, Inc. includes the following individuals:<BR><BR>- Ms. Elizabeth Tallett, who serves as the Independent Chairman of the Board.<BR>- Ms. Gail Boudreaux, who is the President, Chief Executive Officer, and Director.<BR>- Mr. R. Kerry Clark, who is an Independent Director.<BR>- Mr. Robert Dixon, who is also an Independent Director.<BR>- Mr. Lewis Hay, another Independent Director.<BR>- Ms. Julie Hill, who serves as an Independent Director.<BR>- Dr. Bahija Jallal, who is an Independent Director.<BR><BR>This team plays a crucial role in guiding the company's strategic direction and governance.

Read More

Is Elevance Health, Inc. overvalued or undervalued?

20-Sep-2025

As of July 31, 2025, Elevance Health, Inc. is considered overvalued with a P/E ratio of 15 compared to its peers and has underperformed the S&P 500 significantly, with year-to-date returns of -14.40% and a 1-year return of -41.47%.

As of 31 July 2025, the valuation grade for Elevance Health, Inc. has moved from very expensive to expensive, indicating a slight improvement but still suggesting that the stock is not attractively priced. Based on the current metrics, Elevance Health appears to be overvalued. The P/E ratio stands at 15, while its peers, such as UnitedHealth Group, Inc. and The Cigna Group, have P/E ratios of 13.13 and 15.76, respectively, indicating that Elevance Health's valuation is higher than some of its competitors. Additionally, the EV to EBITDA ratio is notably high at 59.39, further supporting the overvaluation thesis.<BR><BR>In terms of recent performance, Elevance Health has underperformed compared to the S&P 500, with a year-to-date return of -14.40% versus the S&P 500's 12.22%. This trend continues over longer periods, with a 1-year return of -41.47% compared to the S&P 500's 17.14%, and a 3-year return of -34.25% against the S&P 500's 70.41%. These figures reinforce the notion that Elevance Health is currently overvalued in the market.

Read More

Is Elevance Health, Inc. technically bullish or bearish?

07-Oct-2025

As of October 3, 2025, Elevance Health, Inc. shows a neutral technical trend with mixed indicators, including a mildly bullish weekly MACD and a bearish monthly MACD, while outperforming the S&P 500 recently but underperforming over the past year, suggesting caution in the current market.

As of 3 October 2025, the technical trend for Elevance Health, Inc. has changed from mildly bearish to sideways. The current technical stance is neutral, with mixed indicators. The weekly MACD is mildly bullish, while the monthly MACD is bearish. The weekly RSI shows no signal, but the monthly RSI is bullish. Moving averages indicate a mildly bearish trend on the daily timeframe. The stock has outperformed the S&P 500 over the past week and month, returning 9.46% and 11.57% respectively, but has underperformed over longer periods, with a 1-year return of -28.88% compared to the S&P 500's 17.82%. Overall, the mixed signals suggest caution in the current market environment.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 14.83%

 
2

Poor long term growth as Operating profit has grown by an annual rate of -306.99%

 
3

Flat results in Jun 25

4

With ROE of 13.90%, it has a expensive valuation with a 2.09 Price to Book Value

5

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Healthcare Services

stock-summary
Market cap

USD 69,391 Million (Large Cap)

stock-summary
P/E

15.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

173.23%

stock-summary
Debt Equity

-0.11

stock-summary
Return on Equity

12.23%

stock-summary
Price to Book

1.59

Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
1,744 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
8.26%
0%
8.26%
6 Months
-12.26%
0%
-12.26%
1 Year
-16.65%
0%
-16.65%
2 Years
-30.97%
0%
-30.97%
3 Years
-36.31%
0%
-36.31%
4 Years
-15.57%
0%
-15.57%
5 Years
3.16%
0%
3.16%

Elevance Health, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Elevance Health, Inc. Experiences Evaluation Revision Amidst Mixed Market Performance Indicators

Elevance Health, Inc. Experiences Evaluation Revision Amidst Mixed Market Performance Indicators

Elevance Health, Inc. has recently revised its evaluation amid fluctuating market conditions. The stock has experienced a notable decline over the past year, contrasting with the S&P 500's performance. Technical indicators show mixed signals, while recent returns indicate short-term outperformance despite longer-term challenges. Ongoing performance monitoring is essential.

Read More

Is Elevance Health, Inc. technically bullish or bearish?

As of 3 October 2025, the technical trend for Elevance Health, Inc. has changed from mildly bearish to sideways. The current technical stance is neutral, with mixed indicators. The weekly MACD is mildly bullish, while the monthly MACD is bearish. The weekly RSI shows no signal, but the monthly RSI is bullish. Moving averages indicate a mildly bearish trend on the daily timeframe. The stock has outperformed the S&P 500 over the past week and month, returning 9.46% and 11.57% respectively, but has underperformed over longer periods, with a 1-year return of -28.88% compared to the S&P 500's 17.82%. Overall, the mixed signals suggest caution in the current market environment....

Read More
Elevance Health Stock Hits Day High with Strong Intraday Performance

Elevance Health Stock Hits Day High with Strong Intraday Performance

Elevance Health, Inc. has seen a significant increase in its stock price today, contrasting with the modest rise of the S&P 500. Over the past week, the company has outperformed the index. However, its long-term performance reveals challenges, with a notable decline over the past year. The company has a market cap of approximately USD 69.39 billion and strong financial metrics, including a high dividend yield and substantial institutional ownership.

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
10.87%
EBIT Growth (5y)
-306.99%
EBIT to Interest (avg)
0.04
Debt to EBITDA (avg)
19.11
Net Debt to Equity (avg)
0.69
Sales to Capital Employed (avg)
2.55
Tax Ratio
24.32%
Dividend Payout Ratio
25.39%
Pledged Shares
0
Institutional Holding
95.20%
ROCE (avg)
0.14%
ROE (avg)
14.83%
Valuation key factors
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
2.09
EV to EBIT
NA
EV to EBITDA
59.39
EV to Capital Employed
2.19
EV to Sales
0.47
PEG Ratio
NA
Dividend Yield
179.04%
ROCE (Latest)
ROE (Latest)
13.90%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 210 Schemes (36.74%)

Foreign Institutions

Held by 567 Foreign Institutions (22.43%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -20.15% vs 428.81% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "380.00",
          "val2": "373.00",
          "chgp": "1.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "341.00",
          "val2": "344.00",
          "chgp": "-0.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,744.00",
          "val2": "2,184.00",
          "chgp": "-20.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "52.90%",
          "val2": "64.20%",
          "chgp": "-1.13%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -0.33% vs 1.75% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,393.00",
          "val2": "1,745.00",
          "chgp": "-20.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1,185.00",
          "val2": "1,030.00",
          "chgp": "15.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5,971.00",
          "val2": "5,991.00",
          "chgp": "-0.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "50.30%",
          "val2": "51.00%",
          "chgp": "-0.07%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
380.00
373.00
1.88%
Interest
341.00
344.00
-0.87%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1,744.00
2,184.00
-20.15%
Operating Profit Margin (Excl OI)
52.90%
64.20%
-1.13%
USD in Million.
stock-summary Compare with Peers
Net Sales

QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -20.15% vs 428.81% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
1,393.00
1,745.00
-20.17%
Interest
1,185.00
1,030.00
15.05%
Exceptional Items
0.00
0.00
Consolidate Net Profit
5,971.00
5,991.00
-0.33%
Operating Profit Margin (Excl OI)
50.30%
51.00%
-0.07%
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -0.33% vs 1.75% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Elevance Health, Inc. stock-summary
stock-summary
Elevance Health, Inc.
Healthcare Services
Anthem, Inc. is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products. It also provides an array of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs and other administrative services. It provides an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits and radiology benefit management.
Company Coordinates stock-summary
Company Details
220 Virginia Avenue , INDIANAPOLIS IN : 46204
stock-summary
Tel: 1 317 4886000
stock-summary
https://www.antheminc.com/
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."